“acceleron” Archives

in
Entry Author Date Location
Bio Roundup: Pelosi’s Reveal, Alder’s Deal, Biogen’s Fails & More 09/20/19 National
Acceleron’s Blood Drug Hits Phase 3 Goals, Paves Way for FDA Filing 06/28/18 Boston
The Year In New York Biotech—Still Trying to Make It Here 12/28/12 New York
Directr and NEVCA Team Up on Boston Startup Holiday Videos 12/18/12 Boston
Celgene Pours $15M Into Acetylon, Takes “Observer” Role on Board 02/09/12 Boston
Celgene Buys Avila for $350M, Gaining Promising “Covalent” Drugs 01/26/12 Boston
Acceleron Adds $30M From Partner Celgene and Existing Investors 12/23/11 Boston
Editor’s Picks: Xconomy Boston’s Top 20 Stories of the Third Quarter 10/28/11 Boston
Shire Finds Big Value in Rare Diseases, and a Strong Growth Path for its Boston Unit 05/12/11 New York
Acceleron Weans Itself Off VC, Continues its Roll with Pharma Partner Dollars 09/28/10 Boston
A Graceful Exit for Gloucester, Pink Slips at Sermo, A Half a Billion Bucks for Vertex, & More Boston-Area Life Sciences News 12/09/09 Boston
Acceleron Doubles Lab Space, Ramps Up Hiring 06/16/08 Boston
Parexel To Purchase ClinPhone for $182M 06/13/08 Boston
Page 1 of 1